Chinese Journal of Antituberculosis ›› 2023, Vol. 45 ›› Issue (3): 318-322.doi: 10.19982/j.issn.1000-6621.20220500
• Review Articles • Previous Articles Next Articles
Received:
2022-12-20
Online:
2023-03-10
Published:
2023-03-07
Contact:
Bian Yanzhu
E-mail:heyixue8144@126.com
CLC Number:
Hu Yujing, Bian Yanzhu. Application value of 18F-FDG PET/CT in diagnosis and treatment of tuberculosis[J]. Chinese Journal of Antituberculosis, 2023, 45(3): 318-322. doi: 10.19982/j.issn.1000-6621.20220500
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20220500
[1] | World Health Organization.Global tuberculosis report 2022. Geneva: World Health Organization, 2022. |
[2] |
吴峰, 华丛书, 张朝东, 等. 21例疑诊为肺癌的新型隐球菌病患者的临床探究. 中华胸心血管外科杂志, 2020, 36(6): 346-350. doi:10.3760/cma.j.cn112434-20191011-00352.
doi: 10.3760/cma.j.cn112434-20191011 |
[3] |
杨珣, 万自芬, 饶珊珊, 等. 肺腺癌误诊为淋巴瘤及淋巴结核病1例. 中国癌症防治杂志, 2020, 12(2): 237-238. doi:10.3969/j.issn.1674-5671.2020.02.24.
doi: 10.3969/j.issn.1674-5671.2020.02.24 |
[4] |
Reinfeld BI, Madden MZ, Wolf MM, et al. Cell-programmed nutrient partitioning in the tumour microenvironment. Nature, 2021, 593(7858):282-288. doi:10.1038/s41586-021-03442-1.
doi: 10.1038/s41586-021-03442-1 URL |
[5] |
宋其生, 路希维. 正电子发射计算机体层摄影-CT在肺结核临床研究中的应用进展与展望. 中国防痨杂志, 2020, 42(6):621-625. doi:10.3969/j.issn.1000-6621.2020.06.015.
doi: 10.3969/j.issn.1000-6621.2020.06.015 |
[6] |
杨贵生, 洪邓辉, 陈子鑫, 等. 肺外结核77例临床特点及18F-脱氧葡萄糖正电子发射体层摄影术/CT影像特征分析. 实用医学影像杂志, 2022, 23(4):360-364. doi:10.16106/j.cnki.cn14-1281/r.2022.04.010.
doi: 10.16106/j.cnki.cn14-1281/r.2022.04.010 |
[7] |
Soussan M, Brillet PY, Mekinian A, et al. Patterns of pulmonary tuberculosis on FDG-PET/CT. Eur J Radiol, 2012, 81(10):2872-2876. doi:10.1016/j.ejrad.2011.09.002.
doi: 10.1016/j.ejrad.2011.09.002 pmid: 21945403 |
[8] |
Li Q, Li Y, Yuan H, et al. PET morphology helps distinguish solitary and solid pulmonary tuberculosis from non-small cell lung cancer. Jpn J Radiol, 2022,10. doi:10.1007/s11604-022-01351-5.
doi: 10.1007/s11604-022-01351-5 |
[9] |
周俊, 毛武剑, 顾宇参, 等. 18F-FDG PET/CT在局灶性机化性肺炎诊断中的应用. 中华核医学与分子影像杂志, 2020, 40(8):464-469. doi:10.3760/cma.j.cn321828-20191205-00287.
doi: 10.3760/cma.j.cn321828-20191205 |
[10] |
Liao F, Huang Z, Xu R, et al. Analysis of misdiagnosis and 18F-FDG PET/CT findings of lymph node tuberculosis. J Xray Sci Technol, 2022, 30(5):941-951. doi:10.3233/XST-221195.
doi: 10.3233/XST-221195 |
[11] |
Hu Y, Zhao X, Zhang J, et al. Value of 18F-FDG PET/CT radiomic features to distinguish solitary lung adenocarcinoma from tuberculosis. Eur J Nucl Med Mol Imaging, 2021, 48(1):231-240. doi:10.1007/s00259-020-04924-6.
doi: 10.1007/s00259-020-04924-6 URL |
[12] |
古嘉媚, 任云燕, 陈小慧, 等. 肿块型活动性肺结核的18F-FDG PET/CT影像表现及其与肺癌的鉴别. 南方医科大学学报, 2020, 40(1):49-55. doi:10.12122/j.issn.1673-4254.2020.01.08.
doi: 10.12122/j.issn.1673-4254.2020.01.08 |
[13] |
赵军, 林祥通, 管一晖, 等. 双时相PET显像在肺良恶性病变鉴别诊断中的应用. 中华核医学杂志, 2003, 23(1):8-10. doi:10.3760/cma.j.issn.0253-9780.2003.01.002.
doi: 10.3760/cma.j.issn.0253-9780.2003.01.002 |
[14] |
徐建平, 张旭, 褚洁, 等. 移植肾结核超声表现及相关文献复习. 中华医学超声杂志(电子版), 2020, 17(2):178-180. doi:10.3877/cma.j.issn.1672-6448.2020.02.0017.
doi: 10.3877/cma.j.issn.1672-6448.2020.02.0017 |
[15] |
曹瑛, 马天丽, 李俊, 等. 慢阻肺合并肺结核患者免疫功能、凝血功能与肺功能相关因子水平和临床意义. 江苏预防医学, 2021, 32(2):163-166. doi:10.13668/j.issn.1006-9070.2021.02.012.
doi: 10.13668/j.issn.1006-9070.2021.02.012 |
[16] |
高丽, 庞学文, 万莹, 等. 天津市综合医疗机构在四种高危人群中开展结核病确诊相关检查现况调查. 中国防痨杂志, 2022, 44(4):397-402. doi:10.19982/j.issn.1000-6621.20220018.
doi: 10.19982/j.issn.1000-6621.20220018 |
[17] |
李运葵, 何金戈, 苏茜, 等. 结核病症状筛查在四川省布拖县HIV感染/AIDS患者中发现结核病患者的价值. 中国防痨杂志, 2020, 42(9):937-941. doi:10.3969/j.issn.1000-6621.2020.09.010.
doi: 10.3969/j.issn.1000-6621.2020.09.010 |
[18] |
饶立歆, 肖筱, 陈静, 等. 结核病与艾滋病低流行地区MTB/HIV双重感染患者发现模式的效果评价. 中国防痨杂志, 2021, 43(3):240-247. doi:10.3969/j.issn.1000-6621.2021.03.009.
doi: 10.3969/j.issn.1000-6621.2021.03.009 |
[19] |
Long W, Cai F, Wang X, et al. High risk of activation of 1alent tuberculosis infection in rheumatic disease patients. Infect Dis (Lond),2020, 52(2):80-86. doi:10.1080/23744235.2019.1682187.
doi: 10.1080/23744235.2019.1682187 |
[20] |
唐果, 龙丽, 韩雅欣, 等. 类风湿关节炎合并结核感染的临床特点及相关因素. 北京大学学报(医学版), 2020, 52(6):1029-1033. doi:10.19723/j.issn.1671-167X.2020.06.007.
doi: 10.19723/j.issn.1671-167X.2020.06.007 |
[21] |
Pettipher C, Benitha R. Tuberculosis in biologic users for rheumatic diseases:results from the South African Biologics Registry(SABIO). Ann Rheum Dis, 2020, 79(2):292-299. doi:10.1136/annrheumdis-2019-216128.
doi: 10.1136/annrheumdis-2019-216128 |
[22] |
Stelzmueller I, Huber H, Wunn R, et al. 18F-FDG PET/CT in the Initial Assessment and for Follow-up in Patients With Tuberculosis. Clin Nucl Med, 2016, 41 (4):e187-94. doi:10.1097/RLU.0000000000001102.
doi: 10.1097/RLU.0000000000001102 URL |
[23] |
Maramattom BV, Santhamma SGN. Tuberculous Encephalitis May Be Undetectable on Magnetic Resonance Imaging but Detectable on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography. Am J Trop Med Hyg, 2021, 105(4):1031-1037. doi:10.4269/ajtmh.21-0288.
doi: 10.4269/ajtmh.21-0288 URL |
[24] |
Ghesani N, Patrawalla A, Lardizabal A, et al. Increased cellular activity in thoracic lymph nodes in early human latent tuberculosis infection. Am J Respir Crit Care Med. 2014, 189(6):748-750. doi:10.1164/rccm.201311-1976LE.
doi: 10.1164/rccm.201311-1976LE URL |
[25] |
李多, 吕平欣. 正电子发射计算机断层显像-CT在肺结核活动性评价中的价值. 中国防痨杂志, 2022, 44(4):409-411. doi:10.19982/j.issn.1000-6621.20210712.
doi: 10.19982/j.issn.1000-6621.20210712 |
[26] |
吴立伟, 王琳, 温子禄, 等. 基于正电子发射断层显像和转录组学对痰菌阴性肺结核病变组织的活动性生物标志物筛选和初步验证. 中华结核和呼吸杂志, 2022, 45(6):567-572. doi:10.3760/cma.j.cn112147-20211207-00864.
doi: 10.3760/cma.j.cn112147-20211207-00864 |
[27] |
Jeong Y, Paeng J, Nam H, et al. (18)F-FDG positron emission tomography/computed tomography findings of radiographic lesions suggesting old healed tuberculosis. J Korean Med Sci, 2014, 29(3):386-391. doi:10.3346/jkms.2014.29.3.386.
doi: 10.3346/jkms.2014.29.3.386 URL |
[28] |
郭玲玲, 卢其玲, 邵明岩, 等. PET-CT联合HRCT扫描对不同大小孤立性肺结节良恶性鉴别的临床价值. 江西医药, 2018, 53(11):1197-1199,1218. doi:10.3969/j.issn.1006-2238.2018.11.003.
doi: 10.3969/j.issn.1006-2238.2018.11.003 |
[29] |
Ji Y, Shao C, Cui Y, et al. 18F-FDG PositronEmission Tomography/Computed Tomography Findings of Radiographic Lesions Suggesting Old Healed Pulmonary Tuberculosis and High-risk Signs of Predicting Recurrence: A Retrospective Study. Sci Rep, 2019, 9(1):12582. doi:10.1038/s41598-019-49057-5.
doi: 10.1038/s41598-019-49057-5 URL |
[30] |
Sood A, Mittal B, Modi M, et al. 18F-FDG PET/CT in Tuberculosis: Can Interim PET/CT Predict the Clinical Outcome of the Patients? Clin Nucl Med, 2020, 45(4):276-282. doi:10.1097/RLU.0000000000002968.
doi: 10.1097/RLU.0000000000002968 pmid: 32108701 |
[31] |
Chen R, Dodd L, Lee M, et al. PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis. Sci Transl Med, 2014, 6(265):265ra166. doi:10.1126/scitranslmed.3009501.
doi: 10.1126/scitranslmed |
[32] |
Martinez V, Castilla-Lievre M, Guillet-Caruba C, et al. 18F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response. Int J Tuberc Lung Dis, 2012, 16(9):1180-1185. doi:10.5588/ijtld.12.0010.
doi: 10.5588/ijtld.12.0010 pmid: 22794271 |
[33] |
Park I, Ryu J, Shim T, et al. Evaluation of therapeutic response of tuberculoma using F-18 FDG positron emission tomography. Clin Nucl Med, 2008, 33(1):1-3. doi:10.1097/RLU.0b013e31815c5128.
doi: 10.1097/RLU.0b013e31815c5128 pmid: 18097246 |
[34] |
Esmail H, Lai R, Lesosky M, et al. Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[F]fluoro-D-glucose positron emission and computed tomography. Nat Med, 2016, 22(10):1090-1093. doi:10.1038/nm.4161.
doi: 10.1038/nm.4161 pmid: 27595321 |
[35] |
French M. HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis, 2009, 48(1):101-107. doi:10.1086/595006.
doi: 10.1086/595006 pmid: 19025493 |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||